Citation Impact
Citing Papers
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
2016 StandoutScienceNobel
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Estrogen receptors and human disease
2006 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application
1995
Mechanisms of Action and Clinical Uses of Estramustine
1990
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
1994 StandoutNature
Chemistry challenges in lead optimization: silicon isosteres in drug discovery
2003
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
1994 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Steroid hormone receptors: Many Actors in search of a plot
1995 Standout
Production and Actions of Estrogens
2002 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
In Vitro Approaches to the Mechanism of Cell-Mediated Immune Reactions
1971
Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens.
1977 StandoutNobel
Production of Macrophage Migration Inhibition Factors by Virus-Infected Cell Cultures
1973 StandoutNobel
THE INTERACTION OF PARTICULATE HORSERADISH PEROXIDASE (HRP)-ANTI HRP IMMUNE COMPLEXES WITH MOUSE PERITONEAL MACROPHAGES IN VITRO
1972 StandoutNobel
PRODUCTION OF MACROPHAGE MIGRATION INHIBITION FACTOR BY CONTINUOUS CELL LINES
1972
Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex
1975 StandoutNatureNobel
The Staphylococcal Enterotoxins and Their Relatives
1990 StandoutScience
Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells
1977 StandoutNobel
THE ROLE OF STREPTOCOCCI IN HUMAN GLOMERULONEPHRITIS
1971
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
1985
Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate
2002
Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.
1979 StandoutNobel
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Antibody-Dependent Lymphoid Cell-Mediated Cytotoxicity: No Requirement for Thymus-Derived Lymphocytes
1972 Science
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.
1976 StandoutNobel
Increased Temperature of Malignant Urinary Bladder Tumors In Vivo: The Application of a New Method Based on a Catheter Technique
2001
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Flow cytometry in clinical cancer research.
1983
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells
1972
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA
1980
The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.
1970
Cloning of a novel receptor expressed in rat prostate and ovary.
1996 Standout
Mechanisms of Estrogen Action
2001 Standout
Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes
1970
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.
1978 StandoutNobel
Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor Immunity
1974 Standout
Serum Migration-Inhibitory Activity in Patients with Lymphoproliferative Diseases
1974 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene.
1995 StandoutNobel
New cell cycle compartments identified by multiparameter flow cytometry
1980
Failure of Certain Cytotoxic Lymphocytes to respond mitotically to Phytohaemagglutinin
1970 Nature
H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.
1975 StandoutNobel
Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products
1977 StandoutNobel
Vitamin D Status in Urinary Calcium Stone Formation
1985
Cell Cycle Regulation in Yeast
1986 StandoutNobel
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
1972 Standout
Rapid activation of haemostasis after hormonal emergency contraception
2007
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.
1975 StandoutNobel
Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate
2002
Cytotoxic Effects of Lymphoid Cells in Vitro
1969
GENETIC CONTROL OF THYMUS-DERIVED CELL FUNCTION
1972 StandoutNobel
Cytological observations on the cytotoxic interaction between lymphocytes and antibody-coated monolayer cells
1973
THE PRODUCTION OF MIGRATION INHIBITION FACTOR BY B AND T CELLS OF THE GUINEA PIG
1973 StandoutNobel
T‐Cell‐Mediated Immunopathology in Viral Infections
1974 StandoutNobel
Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens.
1970
Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
1978 StandoutNobel
A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS
1975 StandoutNobel
Specificity of Virus‐Immune Effector T Cells for H‐2K or H‐2D Compatible Interactions: Implications for H‐Antigen Diversity
1976 StandoutNobel
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.
1978 StandoutNobel
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
1975 StandoutNobel
Works of L Collste being referenced
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
1989
In Vitro Detection of Transplantation Immunity: The Inhibition of Migration of Immune Spleen Cells and Peripheral Blood Leukocytes by Specific Antigen
1970
Relation Between Hypercalciuria and Vitamin D3-Status in Patients with Urolithiasis
1982
Estrogen therapy and liver function—metabolic effects of oral and parenteral administration
1989
Flow Cytometry in Bladder Cancer Detection and Evaluation Using Acridine Orange Metachromatic Nucleic Acid Staining of Irrigation Cytology Specimens
1980
Release of Migration Inhibitory Factors from Immune Rat Lymphocytes confronted with Histocompatibility Antigens
1969 Nature
Cytotoxicity of Human Lymphocytes: Antagonism between Inducing Processes
1968 Nature
Flow cytometry of low stage bladder tumors: Correlation with cytologic and cystoscopic diagnosis
1982
Regional lymph node reactivity in explanted bladder cancer of mice as measured by flow cytometry.
1979
Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
1980
In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens.
1969
Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid
1980
Clinical Trial of a New Antigonadotropic Substance, 2,6-Cis-Diphenylhexamethylcyclotetrasiloxane, in Cancer of the Prostate
1981
Identification of polymorphonuclear leukocytes in cytologic samples for flow cytometry.
1979
Single Drug Polyestradiol Phosphate Therapy in Pro static Cancer
1988